دورية أكاديمية
Rhino-orbital-cerebral-mucormycosis in COVID-19: A systematic review.
| العنوان: | Rhino-orbital-cerebral-mucormycosis in COVID-19: A systematic review. |
|---|---|
| المؤلفون: | Bhattacharyya A; Department of Ophthalmology, Government Medical College and Hospital, Bathinda, Punjab, India., Sarma P; Department of Pharmacology, PGIMER, Bathinda, Punjab, India., Sharma DJ; Department of Internal Medicine, Silchar Medical College and Hospital, Assam, India., Das KK; Department of Anaesthesia, Assam Medical College and Hospital, Assam, India., Kaur H; Department of Pharmacology, PGIMER, Bathinda, Punjab, India., Prajapat M; Department of Pharmacology, PGIMER, Bathinda, Punjab, India., Kumar S; Department of Pharmacology, PGIMER, Bathinda, Punjab, India., Bansal S; Department of Pharmacology, PGIMER, Bathinda, Punjab, India., Prakash A; Department of Pharmacology, PGIMER, Bathinda, Punjab, India., Avti P; Biophysics, PGIMER, Bathinda, Punjab, India., Thota P; Scientific Officer, Department of Pharmacology, Indian Pharmacopoeia Commission, Ghaziabad, Uttar Pradesh, India., Reddy DH; Department of Pharmacology, Central University of Punjab, Bathinda, Punjab, India., Gautam BS; Department of Microbiology, Assam Medical College and Hospital, Assam, India., Medhi B; Department of Pharmacology, PGIMER, Bathinda, Punjab, India. |
| المصدر: | Indian journal of pharmacology [Indian J Pharmacol] 2021 Jul-Aug; Vol. 53 (4), pp. 317-327. |
| نوع المنشور: | Journal Article; Systematic Review |
| اللغة: | English |
| بيانات الدورية: | Publisher: Medknow Publications Country of Publication: India NLM ID: 7902477 Publication Model: Print Cited Medium: Internet ISSN: 1998-3751 (Electronic) Linking ISSN: 02537613 NLM ISO Abbreviation: Indian J Pharmacol Subsets: MEDLINE |
| أسماء مطبوعة: | Publication: Mumbai : Medknow Publications Original Publication: Pondicherry, Published for the Indian Pharmacological Society by the Dept. of Pharmacology, Jawaharial Institute of Postgraduate Medical Education and Research, [1969?]- |
| مواضيع طبية MeSH: | Coinfection*, COVID-19/*virology , Meningitis, Fungal/*microbiology , Mucormycosis/*microbiology , Nose Diseases/*microbiology , Opportunistic Infections/*microbiology , Orbital Diseases/*microbiology , SARS-CoV-2/*pathogenicity, Antifungal Agents/therapeutic use ; COVID-19/immunology ; COVID-19/mortality ; Host-Pathogen Interactions ; Humans ; Meningitis, Fungal/drug therapy ; Meningitis, Fungal/immunology ; Meningitis, Fungal/mortality ; Mucormycosis/drug therapy ; Mucormycosis/immunology ; Mucormycosis/mortality ; Nose Diseases/drug therapy ; Nose Diseases/immunology ; Nose Diseases/mortality ; Opportunistic Infections/drug therapy ; Opportunistic Infections/immunology ; Opportunistic Infections/mortality ; Orbital Diseases/drug therapy ; Orbital Diseases/immunology ; Orbital Diseases/mortality ; Prognosis ; Risk Assessment ; Risk Factors ; SARS-CoV-2/immunology |
| مستخلص: | Since the onset of COVID-19 pandemic, parallel opportunistic infections have also been emerging as another disease spectrum. Among all these opportunistic infection, mucormycosis has become a matter of concern with its rapid increase of cases with rapid spread as compared to pre-COVID-19 era. Cases have been reported in post-COVID-19-related immune suppression along with the presence of comorbidity which adds on the deadly outcome. There is no systematic review addressing the issue of COVID-19-associated mucormycosis. This is the first systematic review of published studies of mucormycosis associated with COVID-19. The aim was to analyze the real scenario of the disease statement including all the published studies from first November 2019 to 30th June to analyze the contemporary epidemiology, clinical manifestations, risk factor, prognosis, and treatment outcome of COVID-19 associated rhino-orbito-cerebral-mucormycosis. A comprehensive literature search was done in following databases, namely, PubMed, Google Scholar, Scopus, and EMBASE using keywords mucormycosis, rhino orbital cerebral mucormycosis, COVID-19, and SARS-CoV-2 (from November 01, 2019 to June 30, 2021). Our study shows that, while corticosteroids have proved to be lifesaving in severe to critical COVID-19 patients, its indiscriminate use has come with its price of rhino-orbito-cerebral mucormycosis epidemic, especially in India especially in patients with preexisting diabetes mellitus with higher mortality. Corticosteroid use should be monitored and all COVID-19 patients should be closely evaluated/monitored for sequelae of immunosuppression following treatment. Competing Interests: None |
| References: | Jpn J Ophthalmol. 2021 Jul;65(4):515-525. (PMID: 34057620) J Maxillofac Oral Surg. 2021 Mar 6;:1-8. (PMID: 33716414) Front Med (Lausanne). 2021 May 28;8:645270. (PMID: 34124087) J Craniomaxillofac Surg. 2012 Oct;40(7):584-91. (PMID: 22082732) Indian J Otolaryngol Head Neck Surg. 2019 Mar;71(1):140-143. (PMID: 30906732) Indian J Ophthalmol. 2021 Feb;69(2):244-252. (PMID: 33463566) Indian J Ophthalmol. 2021 Jun;69(6):1563-1568. (PMID: 34011742) J Laryngol Otol. 2021 May;135(5):442-447. (PMID: 33827722) Clin Infect Dis. 2020 Aug 29;:. (PMID: 32860682) J Neuroradiol. 2021 Jun 1;:. (PMID: 34087330) Indian J Med Microbiol. 2021 Jul;39(3):380-383. (PMID: 34052046) Emerg Infect Dis. 2021 May;27(5):1454-1456. (PMID: 33760726) Clin Infect Dis. 2020 Sep 12;71(6):1367-1376. (PMID: 31802125) Emerg Infect Dis. 2021 Sep;27(9):2349-2359. (PMID: 34087089) Clin Microbiol Infect. 2009 Jul;15(7):693-7. (PMID: 19624514) J Fungi (Basel). 2019 Mar 21;5(1):. (PMID: 30901907) Am J Trop Med Hyg. 2019 Apr;100(4):791-797. (PMID: 30652661) Clin Microbiol Infect. 2019 Jan;25(1):26-34. (PMID: 30036666) QJM. 2021 Jun 28;:. (PMID: 34181023) Clin Infect Dis. 2020 Dec 3;71(9):2459-2468. (PMID: 32358954) Indian J Ophthalmol. 2021 Apr;69(4):1002-1004. (PMID: 33727483) Lancet Infect Dis. 2019 Dec;19(12):e405-e421. (PMID: 31699664) Clin Infect Dis. 2012 Feb;54 Suppl 1:S23-34. (PMID: 22247442) Indian J Otolaryngol Head Neck Surg. 2021 Feb 25;:1-4. (PMID: 33649716) Mycoses. 2021 Jun 7;:. (PMID: 34096653) Lancet Respir Med. 2021 Aug;9(8):e77. (PMID: 34090607) |
| فهرسة مساهمة: | Keywords: COVID-19; Corticosteroid; diabetes; fungal co infection; mucormycosis; rhino-orbito-cerebral mucormycosis; supplemental oxygen |
| المشرفين على المادة: | 0 (Antifungal Agents) |
| تواريخ الأحداث: | Date Created: 20210820 Date Completed: 20210908 Latest Revision: 20210915 |
| رمز التحديث: | 20221213 |
| مُعرف محوري في PubMed: | PMC8411962 |
| DOI: | 10.4103/ijp.ijp_419_21 |
| PMID: | 34414911 |
| قاعدة البيانات: | MEDLINE |
Full Text Finder | تدمد: | 1998-3751 |
|---|---|
| DOI: | 10.4103/ijp.ijp_419_21 |